Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 6766 to 6780 of 7712 results

  1. Pembrolizumab with lenvatinib for untreated PD-L1-positive metastatic non-small-cell lung cancer [ID3809]

    Discontinued [GID-TA10697]

    Technology appraisal guidance
    Discontinued

  2. Peramivir for treating influenza [ID828]

    Discontinued [GID-TA10155]

    Technology appraisal guidance
    Discontinued

  3. Atezolizumab with carboplatin or cisplatin and pemetrexed for untreated advanced non-squamous non-small-cell lung cancer [ID1495]

    Discontinued [GID-TA10395]

    Technology appraisal guidance
    Discontinued

  4. Veliparib for induction treatment of previously untreated advanced ovarian, fallopian tube and primary peritoneal cancer in combination with carboplatin and paclitaxel, followed by veliparib maintenance treatment as a monotherapy [ID1561]

    Discontinued [GID-TA10442]

    Technology appraisal guidance
    Discontinued

  5. Lung cancer (non-small cell) - afatinib [ID357]

    Discontinued [GID-TAG422]

    Technology appraisal guidance
    Discontinued

  6. Workplace health for employees with disabilities and long-term conditions

    Discontinued [GID-PHG58]

    NICE guideline
    Discontinued

  7. Inpatient mental health settings

    Discontinued [GID-SGWAVE0701]

    Safe staffing guideline
    Discontinued

  8. Betrixaban for preventing venous thromboembolism in people hospitalised for acute medical conditions [ID913]

    Discontinued [GID-TA10154]

    Technology appraisal guidance
    Discontinued

  9. Furosemide micro-pump for treating oedema associated with heart failure (ID1061)

    Discontinued [GID-TA10179]

    Technology appraisal guidance
    Discontinued

  10. Accident and emergency departments

    Discontinued [GID-SGWAVE0762]

    Safe staffing guideline
    Discontinued

  11. Hypercholesterolemia - mipomersen [ID524]

    Discontinued [GID-TAG437]

    Technology appraisal guidance
    Discontinued

  12. Autologous chondrocyte implantation using 3D collagen matrix (novocart 3D) for treating articular cartilage defects of the knee [ID2707]

    In development [GID-TA10667] Expected publication date: TBC

    Technology appraisal guidance
    In development

  13. Nivolumab for untreated advanced hepatocellular carcinoma [ID1248]

    Discontinued [GID-TA10221]

    Technology appraisal guidance
    Discontinued

  14. GID-MT567 Evoke Spinal Cord Stimulator for managing chronic neuropathic or ischaemic pain

    In development [GID-MT567] Expected publication date: TBC

    Medical technologies guidance
    In development

  15. Venetoclax with ibrutinib and obinutuzumab for untreated chronic lymphocytic leukaemia ID1270

    Discontinued [GID-TA10211]

    Technology appraisal guidance
    Discontinued